Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Technology Stocks : ATPX: Lunn Industries and Technical Products Group merge. -- Ignore unavailable to you. Want to Upgrade?

To: rci who wrote (1555)	4/25/1998 1:21:00 PM
From: Sergio H	Respond to of 1923

I like the split idea also and suggest that anyone interested contact the Co. I received a kind e-mail correcting my earlier post. <A "secondary" offering was and is the term used to describe a second offering - after a company is already public. The current/correct term is a follow-on offering. This is because follow-on offerings may include "primary" or new shares (issued by the company) and/or "secondary" shares (which are already outstanding and included in determining EPS). Equus can only sell approximately 52,000 shares every 3 months (1% of 5,220,000 shares- Rule 144). The only way they can sell a meaningful portion of the 50% of the company they own, is through a follow-on offering. Benefits: There will be NO dilution from sale of Equus' stock. It is already included in the EPS calculation.>

To: rci who wrote (1555)	4/26/1998 4:57:00 PM
From: Sergio H	Read Replies (2) \| Respond to of 1923

JR, The numbers on the 10q reflect a net income increase of 157% and an EPS increase of 71%. These are very good numbers. The report does include costs associated with the merger, all the way near the bottom. I just started looking over the numbers, including the debt refinancing and cash position. By the way, the web site is improving. The Co. fact sheet has correct information as opposed to Yahoo and other internet sites that contain co. capsules. I like to hear from others. Anyone have opinions or comments on ATPX's progress, where it is and where it should be? Sergio